I.Ceram in Judicial Reorganization to Safeguard its Future

On April 24, 2024, the Limoges commercial court approved the placing of the company I.Ceram, a manufacturer of innovative biocompatible ceramic implants, into receivership. This decision, following a request from the company itself, aims to protect the interests of its employees and its technologies, while allowing the continuation of its operations. The observation period is set at six months.

I.Ceram, known for its innovations in the medical field, notably implants loaded with antibiotics intended to treat bone infections, faces difficulties linked to regulatory changes and financing. Despite notable clinical advances and several awards, challenges remain, leading to the need for this legal protection.